Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Regeneron Pharmaceuticals (NQ: REGN )

514.05 USD UNCHANGED
Streaming Delayed Price Updated: 5:06 AM EST, Nov 30, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Regeneron Pharmaceuticals

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Are These The Best Stocks To Watch Tomorrow? 3 Names To Watch
From Stockmarket.com
Have Gilead's Gains Evaporated in the Coronavirus Treatment Race?
Rivals and vaccine developers have pushed this early leader out of the spotlight. 
Tags REGN Market News GILD
From Motley Fool
Looking For Cheap Stocks To Buy On Black Friday? 3 To Watch Before The Economic Rebound
From Stockmarket.com
Top Biotech Stocks To Watch Apart From Pfizer & Moderna
From Stockmarket.com
Is This Coronavirus Treatment Setting Investors Up for Failure?
Big shot organizations are recommending against the use of Gilead's antiviral to treat COVID-19. 
Tags REGN Market News GILD
From Motley Fool
A Small Company Worth Watching
A look at the latest news from Wall Street. 
Tags AZN VOO SPY
From Motley Fool
Market Briefing For Friday, Nov. 27
Perseverance characterizes this stock market, without much 'harvesting' so far, of gains achieved in the most recent upside phase. Consolidation Friday, most likely, will be what we get for the... 
Tags Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
Market Briefing For Wednesday, Nov. 25
A 'return to normalcy' with minimal concerns about radical transformations, especially as relates to fiscal and monetary policy, partially relates to the S&P surge, which was expected to reach the... 
Tags Technology Communications Pharma/Biotech
From Blogs - TalkMarkets
Reinventing Vaccines To Save Lives And The Economy
Pfizer Inc. (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) were the first to deliver good news regarding the efficiency of their coronavirus ... 
Tags Market News MRNA Benzinga
From Benzinga
The Dream Team Disruptors - Einstein's In Biopharma 2020-2021
The trends in the final months of 2020 and moving into 2021 have assembled "The Dream-Team" in saving many lives and the losses in functionalities in those infected with COVID-19 World-Wide Pandemic. 
Tags Healthcare Pharma/Biotech Stocks / Equities
From Blogs - TalkMarkets
Market Briefing For Tuesday, Nov. 24
Optimism combined with significant political appointments by President-Elect Biden, it's time to prepare for the 'Roaring 20's' not the 1930's and I have argued this core case for this era, against all... 
Tags Communications Technology Pharma/Biotech
From Blogs - TalkMarkets
Dow Jones Surges More Than 300 Points, Led By Boeing, Walt Disney, Chevron; What's Wrong With Apple Stock?
The Dow Jones Industrial Average and Russell 2000 small-cap index were the big winners Monday, but technology stocks like Apple and Qualcomm lagged. 
From Investor's Business Daily
Vaccine Monday
China is enforcing new discipline not only on the private sector giants but also on its state-owned companies. 
From Blogs - TalkMarkets
Noteworthy Monday Option Activity: COST, REGN, PYPL
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Costco Wholesale Corp (COST), where a total of 30,525 contracts have traded so far,... 
Tags Stocks
From Market News Video
Can Coronavirus Vaccine Stocks Keep Lifting the Stock Market?
The market woke up a little tired on Monday morning. 
Tags ^IXIC PFE AZN
From Motley Fool
AstraZeneca Dives On Covid Vaccine News, Buoying Moderna, BioNTech
AstraZeneca said its University of Oxford-partnered coronavirus vaccine was 70% effective, on average, in a key study — leading AZN stock to dive Monday. Some patients saw 90% effectiveness. 
From Investor's Business Daily
U.S. coronavirus case tally tops 12 million amid growing fears that Thanksgiving travel will spark another surge of infections
The global case tally for the coronavirus illness COVID-19 rose to 58.7 million on Monday and the U.S. tally rose above 12 million, with new daily infections heading toward 200,0000 a day amid growing... 
Tags WMG UK:AZN MRNA
From MarketWatch
Looking Into Regeneron Pharmaceuticals's Return On Capital Employed
Looking at Q3, Regeneron Pharmaceuticals (NASDAQ: REGN) earned $1.05 billion, a 60.44% increase from the preceding quarter. Regeneron ... 
Tags Earnings General Benzinga
From Benzinga
Should Investors Consider These Coronavirus Stocks After AstraZeneca’s Vaccine News? 3 Names To Watch
From Stockmarket.com
Top 5 Things To Know In The Stock Market This Week
From Stockmarket.com
BlackRock upgrades U.S. stocks but calls for investors to adopt this ‘nuanced’ approach
Positive vaccine developments are giving stocks a shot in the arm for the third straight Monday. 
Tags REGN MRNA DX:DAX
From MarketWatch
40 Stocks Moving in Monday's Pre-Market Session
Gainers IDT Corporation (NYSE: IDT) shares rose 36.7% to $13.00 in pre-market trading. Ideanomics, Inc. (NASDAQ: IDEX) shares ... 
Tags SBE NNDM NIU
From Benzinga
A Peek Into The Markets: US Stock Futures Gain On Covid-19 Vaccine News
Pre-open movers U.S. stock futures traded higher in early pre-market trade on positive vaccine news. Regeneron Pharmaceuticals Inc ... 
Tags CSGP News KFY
From Benzinga
6 Stocks To Watch For November 23, 2020
Some of the stocks that may grab investor focus today are: Wall Street expects Korn Ferry (NYSE: KFY) to report quarterly ... 
Tags WU Earnings Benzinga
From Benzinga
Positive Vaccine News, Economic Recovery Lift Global Markets
Major indices across Asia, Europe, and the U.S. are trading higher on Monday onpositive vaccine newsand economic recovery ... 
Tags TSLA Bonds Eurozone
From Benzinga
Regeneron's COVID-19 Treatment Gets Emergency FDA Approval
The U.S. Food and Drug Administration has issued emergency use authorization for Regeneron Pharmaceuticals, Inc.'s COVID-19 antibody cocktail. Regeneron shares closed $518.74 on Friday, a gain of $4.03... 
Tags Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
Sorrento Therapeutics' Slow-But-Steady Approach to COVID-19
The biotech has taken a broad approach to development, but has it cost the company time? 
Tags SRNE Market News REGN
From Motley Fool
Regeneron Receives Emergency Use Authorization For Covid Antibody Cocktail
Regeneron Pharmaceuticals announced that the antibody cocktail casirivimab and imdevimab administered together, a therapy currently being investigated for use in COVID-19, received Emergency Use... 
Tags Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
Regeneron's Coronavirus Treatment Becomes First Antibody Cocktail to Earn Emergency Use Authorization from FDA
The FDA has granted emergency use authorization to the first COVID-19 treatment option that uses a pair of antibodies to neutralize the novel coronavirus. 
Tags RHHBY LLY REGN
From Motley Fool
Regeneron's COVID Treatment Gets Emergency FDA Approval
The U.S. Food and Drug Administration has issued emergency use authorization for Regeneron Pharmaceuticals Inc's (NASDAQ: REGN) ... 
Tags REGN Market News Reuters
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.